Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2020; 15(02): 285-292
DOI: 10.4103/ajns.AJNS_120_19
Original Article

Histopathological pattern and outcome of posterior fossa tumors in children and adults – A 20-year experience

Abdul Bhat
Department of Neurosurgery, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Muhammed Wani
Department of Neurosurgery, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Altaf Kirmani
Department of Neurosurgery, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Context: The postoperative quality and span of life in posterior fossa tumors (PFTs) is complicated by the residual disease, progression, recurrence, disabilities, and mortality. Aims: The aim of this study is to analyze the link between histopathological type of tumor and outcome in an ethnic Himalayan population of India. Settings and Design: The histopathological records of 410 out of 589 patients were compared with their clinical outcome up to the 1st postoperative year in a single center which amounts to regional epidemiological value of PFTs. Materials and Methods: In this observational study, retrospectively postoperative records of 589 PFTs from November 1990 to December 2010 (20 years) were retrieved, scrutinized, and observed. The postoperative records of 410 patients with proved histopathological examination results were included. Statistical Analysis Used: The statistical law of variance was applied wherever necessary. Results: About 63.2% of 410 operated PTFs were males while females predominated in meningiomas and pineoblastomas. About 31.7% of PFTs were children (below 18 years.). About 54.1% of the cases were histologically malignant. The residual tumors comprised 40.2%, and symptoms of disease progression occurred in 10.9%. The tumor recurrence occurred in 14.3% while 6.0% of the patients developed severe disability. The overall mortality was 11.4% up to the 1st postoperative year, with 18.9% in malignant patients. The first 1-year event-free survival (EFS) for all the patients was 66.0%. While the patients with malignancies had the first 1-year EFS of 47.7%, the histologically benign group had 87.7%. Conclusion: The first 1-year postoperative EFS of histologically benign and some malignant PFTs both in children and adults such as pilocytic astrocytomas, ependymomas, and pineoblastomas was much better (87.7%) than other malignant PTFs.

Key-words:

Children and adults - histopathology - outcome - posterior fossa tumors

Financial support and sponsorship

Nil.




Publication History

Received: 29 April 2019

Accepted: 12 March 2020

Article published online:
16 August 2022

© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cushing H. Experience with the cerebellar medulloblastoma: Critical review. Acta Pathol Microbiol Immunol Scand 1930;7:1-86.
  • 2 Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997;40:11-21.
  • 3 Seol HJ, Kim CH, Park CK, Kim CH, Kim DG, Chung YS, et al. Optimal extent of resection in vestibular schwannoma surgery: Relationship to recurrence and facial nerve preservation. Neurol Med Chir (Tokyo) 2006;46:176-80.
  • 4 Yamakami I, Uchino Y, Kobayashi E, Yamaura A, Oka N. Removal of large acoustic neurinomas (vestibular schwannomas) by the retrosigmoid approach with no mortality and minimal morbidity. J Neurol Neurosurg Psychiatry 2004;75:453-8.
  • 5 Roberti F, Sekhar LN, Kalavakonda C, Wright DC. Posterior fossa meningiomas: Surgical experience in 161 cases. Surg Neurol 2001;56:8-20.
  • 6 Velho V, Agarwal V, Mally R, Palande DA. Posterior fossa meningioma “our experience” in 64 cases. Asian J Neurosurg 2012;7:116-24.
  • 7 Hakuba A, Nishimura S, Tanaka K, Kishi H, Nakamura T. Clivus meningioma: Six cases of total removal. Neurol Med Chir (Tokyo) 1977;17:63-77.
  • 8 Couldwell WT, Fukushima T, Giannotta SL, Weiss MH. Petroclival meningiomas: Surgical experience in 109 cases. J Neurosurg 1996;84:20-8.
  • 9 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
  • 10 Gläsker S. Central nervous system manifestations in VHL: Genetics, pathology and clinical phenotypic features. Fam Cancer 2005;4:37-42.
  • 11 Benzagmout M, Agharbi S, Chakour K, Chaoui ME. Dermoid cyst of the posterior fossa. Neurosciences (Riyadh) 2011;16:153-5.
  • 12 BAUMANN CH, BUCY PC. Paratrigeminal epidermoid tumors. J Neurosurg 1956;13:455-68.
  • 13 Zakrzewski K, Fiks T, Polis L, Liberski PP. Posterior fossa tumours in children and adolescents. A clinicopathological study of 216 cases. Folia Neuropathol 2003;41:251-2.
  • 14 Muzumdar D, Deshpande A, Kumar R, Sharma A, Goel N, Dange N, et al. Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients. J Pediatr Neurosci 2011;6:S78-85.
  • 15 Rutka JT. Medulloblastoma. Clin Neurosurg 1997;44:571-85.
  • 16 Bloom HJ, Bessell EM. Medulloblastoma in adults: A review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 1990;18:763-72.
  • 17 Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, et al. Adult medulloblastoma: Prognostic factors and patterns of relapse. Neurosurgery 2000;47:623-31.
  • 18 Djalilian HR, Hall WA. Malignant gliomas of the cerebellum: An analytic review. J Neurooncol 1998;36:247-57.
  • 19 Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011;20:143-57.
  • 20 Desai KI, Nadkarni TD, Muzumdar DP, Goel A. Prognostic factors for cerebellar astrocytomas in children: A study of 102 cases. Pediatr Neurosurg 2001;35:311-7.
  • 21 Daszkiewicz P, Maryniak A, Roszkowski M, Barszcz S. Long-term functional outcome of surgical treatment of juvenile pilocytic astrocytoma of the cerebellum in children. Childs Nerv Syst 2009;25:855-60.
  • 22 Lesniak MS, Klem JM, Weingart J, Carson BS Sr. Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas. Pediatr Neurosurg 2003;39:314-22.
  • 23 Donaldson SS, Laningham F, Fisher PG. Advances toward an understanding of brainstem gliomas. J Clin Oncol 2006;24:1266-72.
  • 24 Sunderland GJ, Jenkinson MD, Zakaria R. Surgical management of posterior fossa metastases. J Neurooncol 2016;130:535-42.
  • 25 Zhang X, Zhang W, Cao WD, Cheng G, Liu B, Cheng J. A review of current management of brain metastases. Ann Surg Oncol 2012;19:1043-50.
  • 26 Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, et al. The long-term postsurgical prognosis of patients with pineoblastoma. Cancer 2012;118:173-9.
  • 27 Wang YC, Chuang CC, Wei KC, Chang CN, Lee ST, Wu CT, et al. Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas. Sci Rep 2016;6:35743.